WHAT: Clinical trials often provide patients with life-threatening conditions the best - perhaps only - treatment option for their condition. However, unlike Medicare and private and commercial payers, Medicaid is not federally required to cover routine care costs (like physician visits and laboratory studies) for patients on clinical trials. Without the guarantee of coverage, many Medicaid beneficiaries do not have the latest technological and scientific advancements as a treatment option.
Join the Association for Clinical Oncology (ASCO) for a Capitol Hill briefing to learn how the bipartisan CLINICAL TREATMENT Act (H.R. 913) would guarantee coverage of the routine care costs for Medicaid enrollees with life-threatening conditions participating in clinical trials, and help ensure all patients have access to high-quality, high-value cancer care. Time will be allotted for questions.
- Rep. Ben Ray Luján (NM-3), Sponsor of H.R. 913
- Rep. Gus Bilirakis (FL-12), Original cosponsor of H.R. 913
- Dr. Carolyn Hendricks, Association for Clinical Oncology (ASCO), Chair-Elect, Government Relations Committee
- Brittany McKelvey, Childhood cancer survivor and patient research advocate, American Cancer Society Cancer Action Network (ACS CAN)
Wednesday, March 11, 2020
11:00 AM - 12:00 PM ET
*Lunch will be provided
U.S. Capitol Visitor Center
First ST NE, Washington, DC 20515
RSVP: Please contact Rachel Martin at Rachel.firstname.lastname@example.org or 571-483-1383